| 000 | 01868 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514024852.0 | ||
| 264 | 0 | _c20020611 | |
| 008 | 200206s 0 0 eng d | ||
| 022 | _a1470-3203 | ||
| 024 | 7 |
_a10.3317/jraas.2001.014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhu, B | |
| 245 | 0 | 0 |
_aEffects of different durations of pretreatment with losartan on myocardial infarct size, endothelial function, and vascular endothelial growth factor. _h[electronic resource] |
| 260 |
_bJournal of the renin-angiotensin-aldosterone system : JRAAS _cJun 2001 |
||
| 300 |
_a129-33 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAngiotensin II _xblood |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
| 650 | 0 | 4 |
_aArrhythmias, Cardiac _xblood |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aEndothelial Growth Factors _xmetabolism |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aLosartan _xpharmacology |
| 650 | 0 | 4 |
_aLymphokines _xmetabolism |
| 650 | 0 | 4 |
_aMyocardial Infarction _xblood |
| 650 | 0 | 4 |
_aMyocardial Reperfusion Injury _xblood |
| 650 | 0 | 4 |
_aMyocardium _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aRenin _xblood |
| 650 | 0 | 4 | _aVascular Endothelial Growth Factor A |
| 650 | 0 | 4 | _aVascular Endothelial Growth Factors |
| 650 | 0 | 4 |
_aVasodilation _xdrug effects |
| 700 | 1 | _aSun, Y | |
| 700 | 1 | _aSievers, R E | |
| 700 | 1 | _aBrowne, A E | |
| 700 | 1 | _aLee, R J | |
| 700 | 1 | _aChatterjee, K | |
| 700 | 1 | _aParmley, W W | |
| 773 | 0 |
_tJournal of the renin-angiotensin-aldosterone system : JRAAS _gvol. 2 _gno. 2 _gp. 129-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3317/jraas.2001.014 _zAvailable from publisher's website |
| 999 |
_c11787968 _d11787968 |
||